JACQUELYN LEWIS: Open Payments
NPI 1386150746 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,084 in 54 payments from 24 companies in 2025. Trend: 2023 $2,003 · 2024 $1,731 · 2025 $1,084
Food & beverage: $1,084
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 8 | $204 |
| Vanda Pharmaceuticals Inc. | 5 | $135 |
| PFIZER INC. | 5 | $90 |
| Antares Pharma, Inc. | 4 | $82 |
| ABBVIE INC. | 4 | $72 |
| Novo Nordisk Inc | 4 | $70 |
| GlaxoSmithKline, LLC. | 3 | $58 |
| Eisai Inc. | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| Grifols USA, LLC | 1 | $31 |
Products named: Auvelity, FANAPT, XYOSTED, TRELEGY ELLIPTA, Ozempic, ELIQUIS, Leqembi, JARDIANCE.
Industry payments across MI — which companies pay providers there.
